The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Thyroxine Therapy in Patients with Severe Nonthyroidal Illnesses and Low Serum Thyroxine Concentration*
Abstract
A randomized prospective study was done to assess the response of hypothyroxinemic patients with severe nonthyroidal illnesses to T4 therapy. Patients admitted to a medical intensive care unit who had a total serum T4 concentration less than 5 micrograms/dl were randomly assigned to a control (12 patients) or a T4 treatment group (11 patients). L-T4 in a dose of 1.5 micrograms/kg was given iv each day for 2 weeks. In the treatment group, serum T4 and free T4 concentrations significantly increased by day 3 and were normal on day 5. Serum TSH levels decreased significantly in the T4 treatment group, as did the TSH response to TRH. A significant rise in serum T3 occurred in the control group on day 7, but was delayed until day 10 in the treatment group. Mortality was equivalent in the 2 groups (75% control vs. 73% treatment). Regardless of group assignment, survivors and nonsurvivors were completely separable based on baseline T3 to T4 ratios [17.0 +/- 1.8 (+/- SE) ng/micrograms in survivors vs. 7.0 +/- 0.7 in nonsurvivors; P less than 0.001]. Angiotensin-converting enzyme was significantly reduced in the T4 treatment group, but did not rise significantly in response to treatment. T4 therapy was not beneficial in this population of intensive care unit patients, and by inhibiting TSH secretion, it may suppress an important mechanism for normalization of thyroid function during recovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alterations in thyroid function in patients with systemic illness: the euthyroid sick syndrome
WARTOFSKY, L., & BURMAN, K. D. (1982) · Endocrine Reviews · doi:10.1210/edrv-3-2-164 · Cited by 916
Cited by
Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., et al. (2014) · Thyroid® · doi:10.1089/thy.2014.0028 · Cited by 1,928
“They excluded studies that examined patients less than 18 years of age [except for Brent and Hershman (637)], studies of perioperative patients, studies with before and during study design, and studies of TH use for less than 24 hours.”
Bianco, A. C., Salvatore, D., Gereben, B., Berry, M. J., & Larsen, P. R. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0455 · Cited by 1,853
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber, K. A. (2012) · Endocrine Practice · doi:10.4158/ep12280.gl · Cited by 1,567
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber for the American Association, K. A. (2012) · Thyroid · doi:10.1089/thy.2012.0205 · Cited by 1,053
Cellular and Molecular Basis of Deiodinase-Regulated Thyroid Hormone Signaling1
Gereben, B., Zavacki, A. M., Ribich, S., Kim, B. W., Huang, S. A., Simonides, W. S., Zeöld, A., & Bianco, A. C. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0019 · Cited by 891
Insulin resistance and atherosclerosis
Semenkovich, C. F. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29024 · Cited by 481
Dangerous dogmas in medicine: the nonthyroidal illness syndrome
De Groot, L. J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.1.5364 · Cited by 505
Peeters, R. P., Wouters, P. J., Kaptein, E., van Toor, H., Visser, T. J., & Van den Berghe, G. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-022013 · Cited by 452
Thyroid function in critically ill patients
Fliers, E., Bianco, A. C., Langouche, L., & Boelen, A. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00225-9 · Cited by 441
Euthyroid Sick Syndrome: Is It a Misnomer?
Chopra, I. J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.2.3745 · Cited by 374
The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism
Docter, R., Krenning, E. P., de Jong, M., & Hennemann, G. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb02401.x · Cited by 345
Fekete, C., & Lechan, R. M. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1087 · Cited by 342
Non-Thyroidal Illness in the ICU: A Syndrome with Different Faces
Van den Berghe, G. (2014) · Thyroid® · doi:10.1089/thy.2014.0201 · Cited by 316
Novel insights into the neuroendocrinology of critical illness
Van den Berghe, G. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430001 · Cited by 257
Peeters, R. P., Wouters, P. J., van Toor, H., Kaptein, E., Visser, T. J., & Van den Berghe, G. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0535 · Cited by 251
De Groot, L. J. (2006) · Critical Care Clinics · doi:10.1016/j.ccc.2005.10.001 · Cited by 188
Plikat, K., Langgartner, J., Buettner, R., Bollheimer, L. C., Woenckhaus, U., Schölmerich, J., & Wrede, C. E. (2007) · Metabolism · doi:10.1016/j.metabol.2006.09.020 · Cited by 156
Brosnihan, K. B., Li, P., Ganten, D., & Ferrario, C. M. (1997) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1997.273.6.r1908 · Cited by 156
TSH and thyrotropic agonists: key actors in thyroid homeostasis
Dietrich, J. W., Landgrafe, G., & Fotiadou, E. H. (2012) · Journal of Thyroid Research · doi:10.1155/2012/351864 · Cited by 146
Tissue Thyroid Hormone Levels in Critical Illness
Peeters, R. P., van der Geyten, S., Wouters, P. J., Darras, V. M., van Toor, H., Kaptein, E., Visser, T. J., & Van den Berghe, G. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1013 · Cited by 145
Légrádi, G., Emerson, C. H., Ahima, R. S., Flier, J. S., & Lechan, R. M. (1997) · Endocrinology · doi:10.1210/en.138.6.2569 · Cited by 505
Reduced tissue thyroid hormone levels in fatal illness
Arem, R., Wiener, G. J., Kaplan, S. G., Kim, H.-S., Reichlin, S., & Kaplan, M. M. (1993) · Metabolism · doi:10.1016/0026-0495(93)90266-q · Cited by 129
Endocrine Responses to Critical Illness: Novel Insights and Therapeutic Implications
Boonen, E., & Van den Berghe, G. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4115 · Cited by 105
New insights toward the acute non-thyroidal illness syndrome
Wajner, S. M., & Maia, A. L. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00008 · Cited by 105
Thyroid axis function and dysfunction in critical illness
Mebis, L., & Van den Berghe, G. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.03.002 · Cited by 99
Moura Neto, A., & Zantut-Wittmann, D. E. (2016) · International Journal of Endocrinology · doi:10.1155/2016/2157583 · Cited by 91
Reawakened interest in type III iodothyronine deiodinase in critical illness and injury
Huang, S. A., & Bianco, A. C. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0727 · Cited by 95
Yu, J., & Koenig, R. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004866200 · Cited by 94
Thyroxine alone or thyroxine plus triiodothyronine replacement therapy for hypothyroidism
Chao, M., Jiawei, X., Xia, H., Guoming, W., Yangang, W., Xufu, W., & Shuyao, Z. (2009) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e32832c79e0 · Cited by 93
Regulation of Type 1 Iodothyronine Deiodinase in Health and Disease
Koenig, R. J. (2005) · Thyroid · doi:10.1089/thy.2005.15.835 · Cited by 90
Immunohistochemical localization of renin and angiotensin II in human ovaries
Palumbo, A., Jones, C., Lightman, A., Carcangiu, M. L., DeCherney, A. H., & Naftolin, F. (1989) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(89)90077-x · Cited by 75
THYROID HORMONE RECEPTOR EXPRESSION IN THE "SICK EUTHYROID" SYNDROME
WILLIAMS, G. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92930-9 · Cited by 71
The hypothalamic-pituitary-thyroid axis in critical illness
Fliers, E., Alkemade, A., & Wiersinga, W. M. (2001) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.2001.0163 · Cited by 69
Rothberger, G. D., Gadhvi, S., Michelakis, N., Kumar, A., Calixte, R., & Shapiro, L. E. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.10.045 · Cited by 56
Ward, L. S. (2010) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302010000500002 · Cited by 53
Induction of Type 1 Iodothyronine Deiodinase to Prevent the Nonthyroidal Illness Syndrome in Mice
Yu, J., & Koenig, R. J. (2006) · Endocrinology · doi:10.1210/en.2005-1443 · Cited by 46
Mönig, H., Arendt, T., Meyer, M., Kloehn, S., & Bewig, B. (1999) · Intensive Care Medicine · doi:10.1007/s001340051088 · Cited by 44
Dietrich, J. W., Stachon, A., Antic, B., Klein, H. H., & Hering, S. (2008) · BMC Endocrine Disorders · doi:10.1186/1472-6823-8-13 · Cited by 44
Drug-induced endocrine disorders in the intensive care unit
Thomas, Z., Bandali, F., McCowen, K., & Malhotra, A. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181dda0f2 · Cited by 30
Hypothyroidism and Adrenal Insufficiency in Sepsis and Hemorrhagic Shock
Ho, H. C. (2004) · Archives of Surgery · doi:10.1001/archsurg.139.11.1199 · Cited by 25
Circulating 3-T1AM and 3,5-T2 in critically ill patients: a cross-sectional observational study
Langouche, L., Lehmphul, I., Perre, S. V., Köhrle, J., & Van den Berghe, G. (2016) · Thyroid® · doi:10.1089/thy.2016.0214 · Cited by 23
Thyroid Hormone Transport into Cellular Tissue
Holtorf, K. (2014) · Journal of Restorative Medicine · doi:10.14200/jrm.2014.3.0104 · Cited by 16
Fan, S., Ni, X., Wang, J., Zhang, Y., Tao, S., Chen, M., Li, Y., & Li, J. (2016) · Medicine · doi:10.1097/md.0000000000002640 · Cited by 7
Peeters, R. P., & Boelen, A. (2022) · Oxford Textbook of Endocrinology and Diabetes 3e · doi:10.1093/med/9780198870197.003.0042 · Cited by 3
Metadata
- Authors
- BRENT, G. A., & HERSHMAN, J. M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1986-07
- Volume
- 63
- Issue
- 1
- Pages
- 1-8
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1995684114
- Cited by
- 365
- References
- 1
- FWCI
- 4.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
